Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

CORDIS reúne toda la información sobre los proyectos financiados por Horizonte 2020 , y ahora también resúmenes de los informes relacionados. Se puede descargar toda la documentación de estos proyectos en el Portal de datos abiertos de la UE .

My refinements


Download results of this page


Restringir por:

Tipo de contenido

Proyecto (778)
Resultado resumido (72)
Informe resumido (520)

País

Albania (2)
Alemania (376)
Antigua República Yugoslava de Macedonia (5)
Argentina (2)
Australia (18)
Austria (92)
Bangladés (1)
Benín (1)
Bosnia y Herzegovina (1)
Brasil (4)
Bulgaria (11)
Burkina Faso (1)
Bélgica (192)
Camboya (1)
Canadá (17)
Chequia (37)
China (3)
Chipre (14)
Colombia (3)
Corea del Sur (6)
Costa de Marfil (1)
Croacia (20)
Cuba (2)
Dinamarca (138)
Ecuador (1)
Eslovaquia (13)
Eslovenia (38)
España (333)
Estados Unidos (68)
Estonia (23)
Finlandia (89)
Francia (287)
Gabón (2)
Ghana (1)
Grecia (89)
Hungría (38)
India (3)
Irlanda (81)
Islandia (18)
Israel (67)
Italia (303)
Jamaica (1)
Japón (1)
Kirguistán (1)
Kosovo (3)
Letonia (15)
Lituania (3)
Luxemburgo (21)
Malaui (2)
Malta (2)
Moldavia (1)
Montenegro (2)
Mozambique (2)
México (2)
Nepal (2)
Noruega (63)
Nueva Caledonia (1)
Pakistán (2)
Países Bajos (317)
Perú (1)
Polinesia Francesa (1)
Polonia (55)
Portugal (74)
Reino Unido (406)
Rumanía (24)
Rusia (1)
Senegal (4)
Serbia (15)
Sri Lanka (1)
Sudáfrica (5)
Suecia (165)
Suiza (121)
Taiwán (5)
Tanzania (4)
Tayikistán (1)
Turquía (18)
Ucrania (1)
Uganda (6)
Vietnam (1)
Zambia (1)

Advanced search

Búsqueda de proyectos y resultados

Results 1 - 10 of 1370
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Periodic Reporting for period 1 - RHAPSODY (Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification)
Diabetes is subdivided into Type 1 Diabetes (T1D) and Type 2 Diabetes mellitus (T2D). T1D accounts for about 10% of all patients. T2D, which accounts for about 80-90% of all patients, is very heterogeneous, but the extent of this diversity is not known. RHAPSODY explores...
Programme: H2020-EU.3.1.7.6.
Record Number: 232104
Last updated on: 2018-06-22
Periodic Reporting for period 1 - EBODAC (Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.)
The Ebola virus disease (EVD) epidemic has infected more than 28.000 people and killed more than 11.000 from March 2014 to December 2015, the vast majority of them in 3 West African countries: Guinea, Liberia and Sierra Leone (WHO Ebola Situation Report June 10, 2016). No...
Programme: H2020-EU.3.1.7.13.
Record Number: 232106
Last updated on: 2018-06-22
PROMOTING MENTAL WELLBEING IN THE AGEING URBAN POPULATION: DETERMINANTS, POLICIES AND INTERVENTIONS IN EUROPEAN CITIES
ID: 667661
Fecha de inicio: 2016-01-01, Fecha de finalización: 2019-12-31
Major depressive disorder, dementia, anxiety disorders, and substance abuse affect a substantial part of the European older population. Over 70% of Europeans reside in cities, and this percentage will increase in the next decades. Urbanization and ageing have enormous...
Programme: H2020-EU.3.1.4.
Record Number: 199736
Last updated on: 2017-08-17
Improving Diagnosis by Fast Field-Cycling MRI
ID: 668119
Fecha de inicio: 2016-01-01, Fecha de finalización: 2019-12-31
Many diseases are inadequately diagnosed, or not diagnosed early enough by current imaging methods. Examples of unmet clinical needs arise in thromboembolic disease, osteoarthritis, cancer, sarcopenia, and many more areas. Our solution, Fast Field-Cycling (FFC) MRI, can...
Programme: H2020-EU.3.1.3.
Record Number: 199749
Last updated on: 2017-06-23
Investigating the impact of meditation training on mental health and wellbeing in the ageing population
ID: 667696
Fecha de inicio: 2016-01-01, Fecha de finalización: 2020-12-31
As the number of older people in Europe grows, increasing healthy life years is a priority. Cognitive decline, dementia (e.g. Alzheimer’s disease, AD), sleep disturbances and depression, all related to psychological distress and anxiety, are significant drivers of reduced...
Programme: H2020-EU.3.1.4.
Record Number: 199737
Last updated on: 2017-05-18
Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders
ID: 667301
Fecha de inicio: 2016-01-01, Fecha de finalización: 2020-12-31
COSYN integrates outstanding European academic and three large Pharma to exploit genomic findings for intellectual disability (ID), autism, and schizophrenia. We capitalise on comorbidity, from clinic to cells and synapses, and have access to large existing samples. We focus...
Programme: H2020-EU.3.1.1.
Record Number: 199728
Last updated on: 2017-08-05
Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen
ID: 668353
Fecha de inicio: 2016-01-01, Fecha de finalización: 2020-12-31
Pharmacogenomics is the study of genetic variability affecting an individual’s response to a drug. Its use allows personalized medicine and reduction in ‘trial and error’ prescribing leading to more efficacious, safer and cost-effective drug therapy. The U-PGx...
Programme: H2020-EU.3.1.6.
Record Number: 199754
Last updated on: 2017-07-17
Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes
ID: 667191
Fecha de inicio: 2016-01-01, Fecha de finalización: 2019-12-31
Type 2 diabetes (T2D) is a major public health problem, affecting 55 million European citizens. T2D ensues in individuals who develop a progressive pancreatic beta cell failure. T2D probably comprises a heterogeneous group of diseases. A new molecular taxonomy of T2D is...
Programme: H2020-EU.3.1.1.
Record Number: 199723
Last updated on: 2017-05-23
VISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like Intervention on Duchenne Muscular Dystrophy
ID: 667078
Fecha de inicio: 2016-01-01, Fecha de finalización: 2019-12-31
VISION-DMD aims to advance clinical development of the orphan drug VBP15 as a new therapy to revolutionise care for all patients with Duchenne muscular dystrophy (DMD) by 2020, in line with IRDiRC goals. DMD is an incurable, rare muscle wasting disease; boys progressively...
Programme: H2020-EU.3.1.3.
Record Number: 199721
Last updated on: 2017-05-10
Linking Up Environment, Health and Climate for Inter-sector Health Promotion and Disease Prevention in a Rapidly Changing Environment
ID: 666773
Fecha de inicio: 2016-01-01, Fecha de finalización: 2020-06-30
The BlueHealth Consortium brings together a multi-disciplinary team of experts reaching across all 28 European Union countries. The proposed 4.5 year BlueHealth Project takes an international, interdisciplinary and multi-sector approach to health promotion and disease...
Programme: H2020-EU.3.1.2.
Record Number: 199715
Last updated on: 2017-06-16
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2018-06-25
Síganos en: RSS Facebook Twitter YouTube Gestionado por la Oficina de Publicaciones de la UE Arriba